Genmab to acquire Merus for $8 billion
Proposed acquisition adds petosemtamab, a late-stage asset with two Breakthrough Therapy Designations, to Genmab’s portfolio
Proposed acquisition adds petosemtamab, a late-stage asset with two Breakthrough Therapy Designations, to Genmab’s portfolio
The acquisition positions ACL Digital as an end-to-end provider of global clinical research and data CRO solutions
Sanofi Ventures drives innovation through leading and participating in private financing rounds for pioneering healthcare companies
Merck and Siemens signed new MoU extending their strategic partnership to accelerate digital transformation in the life science industry
Pegozafermin offers a distinct mechanism of action with potential for enhanced efficacy and tolerability and opportunities for combination development with incretins
Advent acquired Zentiva from Sanofi in 2018 and transformed the company into a highly successful standalone business
Shantived Hospital generated revenue of around Rs 50 crore in FY2025
Subscribe To Our Newsletter & Stay Updated